Last Price
11.84
Today's Change
-0.27 (2.22%)
Day's Change
11.75 - 12.65
Trading Volume
78,357
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Joel D. Becker Mr. Joel D. Becker
Full Time Employees: 184 184
IPO Date: 2021-04-22 2021-04-22
CIK: 0001528287 0001528287
ISIN: US6412881053 US6412881053
CUSIP: 641288105 641288105
Beta: 1.80 1.80
Last Dividend: 0.00 0.00
Dcf Diff: 14.01 14.01
Dcf: -0.02 -0.02
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.